apart invest manag compani
hold lower estim downgrad hold
pt surpass downgrad hold see
lack catalyst drive continu out-performance
past month versu rmz good same-
store growth significantli better peer
project lowest ffop growth apart coverag
univers meanwhil highest financi leverag
trade roughli line five-year averag discount
look back year find time trade
ffo multipl high lower ffo estim
post pt impli total return michael lewi
specul spark signal pharma increas interest
gene therapi saturday wall street journal wsj
publish articl note roch close deal acquir
spark specul believ
share could least news
gene therapi compani whole also impact
opinion qure particular opinion
believ roch good fit spark given roch presenc
ophthalmolog hemophilia space
continu view spark valu platform play reiter buy
reduc stock pullback overreact
reduc annual estim believ declin
stock price friday overreact base lower
estim reduc price target ali
ahead expect rais price target base latest
peer valuat rais price target
electr power util power/util macro trend
tracker declin forward spread report includ
analysi key macro factor impact power/util
sector includ forward price spark spread dark spread
nation weather pattern base latest peer group
valuat increas price target
 ali agha
consum stapl last week sugar price increas
higher sugar price could neg impact
 biotech monthli monitor preview march
internet digit media internet posit earn to-dat
scorecard idm group
 kc boston new york young
tobey sommer business/govern servic detroit
compani univers bf ko
 william chappel jr
line price target roll-forward est
ebitda goe ep goe
introduc adjust
ebitda ep price target goe
roll target year forward
price target base multipl
wrap fcf/deleverag path begin detail social ipo
 post aebitda in-line consensu
street high estim game segment came
expect despit believ addit detail
potenti ipo social busi drove yesterday
out-performance tweak model aebitda
larg unchang though continu think sciq estimate
see improv investor sentiment remain
buy rate new aebitda estim ahead
street barri jona
review earn miss reset bar
report miss adj ebitdar
model weak primarili driven us partial
off-set lv strip discontinu ebitdar guidanc
provid high-level color net net think remain
transit pend ceo chang conserv
commentari reset expect think investor
stay focus recent activist pressur could off-set
earn weak lower ebitdar
pt though still see valu asset
potenti sharehold valu creation remain buy rate
electr power util
reduc stock pullback overreact
reduc annual estim believ declin
stock price friday overreact base lower
estim reduc price target ali
ahead expect rais price target base latest
peer valuat rais price target
electr power util power/util macro trend
tracker declin forward spread report includ
analysi key macro factor impact power/util
page
sector includ forward price spark spread dark spread
nation weather pattern base latest peer group
valuat increas price target
 ali agha
overdon option earn stock
materi under-perform peer last week fail
impress investor guidanc target near-term
free cash flow gener includ drop rig mid-year
look potenti add rig back earli
pre-budget releas level vs permian
peer xop oil time period
februari though continu question effici
profil associ w/a variabl rig program still forecast
healthi doubl digit product earn growth callon
 neal dingmann
enerplu corpor erf buy crave ice
 enerplu continu solid oper financ via
on-going bakken program produc low double-
digit oil growth within cash flow potenti upsid
along potenti buy back share
compani maintain strong cash posit neal
parsley energi inc pe buy posit best
whichev path taken parsley continu today highlight
rate return focu center upspac much
acr well in-zon space well in-zon
space compani npv focus investor
speak seem recogn valu maxim
section provid suffici acreag
believ strategi posit parsley best whether continu
develop resourc maxim futur sharehold valu
help make compani attract suitor neal
stori modestli reduc near term estim
refin gmt estim expect segreg
storag busi see soft rel recent
period lower previous anticip unit
outperform broader midstream think partli in-lin
print follow neg gmt sentiment head quarter
slightli increas number imo uplift
fine tune capit project develop
reiter price target ebitda hold
continu monster cost diff tweak well
page
review forev andeavor andeavor reduc
target andx sister continu converg
around tighter impli exchang ratio gener expect
unit move around percept around eventu
consolid rather outlook growth rel
unchang estim reduc target
repres modest premium averag exchang
ratio andx sister lp rate unit hold tristan
retir co-ceo alan white michael young
trim corpor segment revenu forecast
million million project
million million accur reflect
revenu run rate follow divestitur pacif union
brokerag oper carri substanti revenu
margin profit oversight part
incorpor model accordingli
segment pre-tax earn forecast million
million respect unchang ep estim
 mark hugh
still reflect transit market trim ep
forecast driven mainli higher current
accid year loss specialti carryov pressur
fourth quarter establish ep forecast
base assum improv accid year loss
partial off-set moder reserv gain current valuat
book appear reason light forecast mid-
single-digit roe uncertain time cyclic recoveri
profit said maintain hold rate
price target estim book valu mark hugh
follow-up rais estim boost
ep forecast establish
forecast given continu acceler top-line
expans along sign opportun
market believ remain attract stock growth
investor look exposur high qualiti financi
rais price target next year
earn line compani recent multipl
lead carrier figur mark hugh
buy trim forecast
correspond mid-point manag guidanc
combin ratio achiev mainli elimin
page
favor reserv develop model
assum bp net earn premium vs bp
previous establish forecast
incorpor top-line growth along bp
improv overal combin ratio reiter
buy rate price target next year earn
still discount peer figur mark hugh
specul spark signal pharma increas interest
gene therapi saturday wall street journal wsj
publish articl note roch close deal acquir
spark specul believ
share could least news
gene therapi compani whole also impact
opinion qure particular opinion
believ roch good fit spark given roch presenc
ophthalmolog hemophilia space
continu view spark valu platform play reiter buy
 inflect point strategi shift yet appar pt
maintain hold maintain hold rate lower pt
highlight reaction note link
result weak guidanc
street appear refocus busi
low visibl confid financi outlook ex-
netsmart opt simplifi model set
think conserv estim just-low pt
base introduc ep estim price-to-earnings
multipl consist year ntm averag multipl
manag enthus geneva updat
fy sale estimate cc report exclud
contribut pend geneva acquisit
cc report vs consensu report
expect set manag exhibit
model adjust ebitda excl sbc
prior in-lin consensu in-lin
adjust ebitda margin guidanc
ep estim unchang vs consensu
 februari saw strength mid-cap
biotech despit sector under-perform broader market
btk nbi vs
follow strong outperfom biotech
indic jan biotech trade price-to-earnings low exh
continu see upsid sector base upon favor
regulatori environ data exh
potenti transform medicin approach approv
page
enter clinic reiter posit outlook space
buy argx arri
 three potenti stock-mov event would
highlight initi data sarepta phase i/iia
trial gene therapi program februari http //
array phase beacon data
believ likelihood posit data
think could potenti drive stock see
preview think pdufa
march could surpris upsid event less-
buy model updat rais pt
updat sales/ep estim
cc cc organ report
vs consensu
forecast gm/om/adj ebitda/tax
prior estim compar
manag guidanc organ
report ep guidanc
rais dcf base pt maintain buy
lentiglobin like data updat -thal/scd
 expect posit chmp opinion lentiglobin
transfus depend -thalassemia
potenti approv like eha congress mid-jun
bluebird present updat data lentiglobin -thal
scd believ investor comfort lentiglobin
efficaci like scrutin emerg safeti signal
compani expect present data program
decemb updat market penetr well
price assumpt lentiglobin reduc pt
maintain buy rate edward nash
icon plc iclr buy clean consist pt
 highlight reaction note link result
solid guidanc reiter book bill remain
strong year end although ep
estim unchang -- top reiter
guidanc rang -- think increment oper leverag
rais pt reflect optim ep growth
turn improv valuat multipl approxim peer
expect head preliminari readout
gene therapi program sarepta report preliminari data
phase i/iia trial februari
page
expect favor result first three patient
believ preclin promis data micro-dystrophin
specif program use vector
promot enabl robust express heart
beta-sarcoglycan posit fiber beta-sarcoglycan
express level compar normal could lead substanti
upsid edward nash
tough less inspir guidanc earli june three-
year top-lin wild card biomarin tough
product except palynziq miss consensu like due
season order pattern latin america although
top-lin revenu guidanc mid-point meet street higher
 sg expens suggest potenti wider net
loss next critic catalyst biomarin compani
announc top-lin three-year data phase i/ii studi
valrox earli june remain wild card sens
manag commentari chanc
see downward trend factor viii activ level edward
prompt weaker outlook downward revis
 maintain hold rate lower pt
follow weak highlight revenue miss
partial off-set tax driven bottom line beat management
outlook consensu seemingli bake
trade-war/tariff settlement correspond stronger
addit account current global macro weak
notabl auto slow china management revis
growth profit assumpt first disclos
sep aerospac remain pillar strength tougher
comp potenti traffic slowdown watch item michael
histor restat adjust histor model
reflect restat financi compani owe
divestitur believ provid better apples-to-
appl comparison current oper adjust
histor financi chang forward-look
estim guidanc provid recent call also made
adjust adjust chang current
thesi maintain buy rate price target frank atkin
 reiter buy rate rais pt
ebitda believ return
least low-singl ex-mortgag organ revenue growth sale
pipelin normal co move next-gen cloud-bas
page
tech platform remain convinc l-t model intact
valuat discount provid downsid protect even
deceler us economi new rev/ebitda
est prior
street
apart invest manag compani
hold lower estim downgrad hold
pt surpass downgrad hold see
lack catalyst drive continu out-performance
past month versu rmz good same-
store growth significantli better peer
project lowest ffop growth apart coverag
univers meanwhil highest financi leverag
trade roughli line five-year averag discount
look back year find time trade
ffo multipl high lower ffo estim
post pt impli total return michael lewi
retail reit reit adjust estim updat
earn estim base fourth
quarter result earn confer call commentari
adjust revenu growth expens assumpt also
increas pt
 ki bin
view lower ffo estim follow
small miss slightli disappoint guidanc
said think guidanc could prove conserv same-
store ffo impli earn growth significantli
differ peer yet stock trade
turn cheaper peer p/ffo p/fad
also trade largest discount rel
histor five-year averag apart reit
coverag univers total return impli pt
second-highest group michael lewi
estim equiti offer rais pt maintain buy
manag target net d/ebtida prior
week equiti offer expect near
new unsecur debt equiti replac much
debt keep leverag low rang price
slightli estim stock near all-tim
high set opportunist and/or defens
futur pt impli fairli modest
upsid second-highest apart coverag
page
univers confid higher
softwar workiva wk intern oppti solution-
base price highlight review fortun compani
announc procur report error mayb sale oppti
instructur inst review terri tillman
internet digit media result week
earn wix last week strong
backdrop rel higher expect macro uncertainti
ytd-season continu show improv top line
out-performance rel support current valuat
view week result
like show remain posit
idm group given demand fundament gener
healthi valuat attract given opportun last week
sti index stii under-perform broader market
report strong result in-line street expect
compani report week feb
expect compani outlook consist
expect show healthi top line growth along
margin gain management commentari drive volum qualiti
lead dealer improv dealer particip traction
growth int market key stock
expect outlook expect report
line result continu make progress
expand product offer improv back-end capabl
posit single-stop platform creativ
content result highlight execut difficulti
guidanc need show dd fxn top line growth
expand ebitda margin street consensu even
face heighten competit potenti remain neutral
get confirm top line re-acceleration/
group inc drop coverag
cf maintain hold risk/reward subscript revenu
y/i report adjust one-tim million
uplift quarter solidli ahead expect solid
outlook y/i subscript revenu growth midpoint
guidanc oper loss better expect
weaker cash flow model explain highlight
call includ strong larg deal expans sale
page
activ well strong perform europ maintain
hold risk/reward rais price target terri
page
feb edgewel person compani ndr president/ceo vice-president ir corpor develop
march corpor ndr ceo head ir boston
march seacoast bank corpor florida ndr ceo cfo west coast
march carguru inc ndr head ir canada kc st loui new
march cousin properti incorpor ndr president/ceo cfo vice-president financ ir chicago
march la jolla compani ndr ceo cfo associ director ir new york new
march inc ndr cfo vice-president ir head global estat west coast
march eventbrit inc eb ndr cfo head ir tx kc new
march inc ndr president/ceo cfo chief staff/vp strateg financ
march piedmont offic realti trust inc ndr presid evp cfo cao boston
april bioscrip inc bio ndr president/ceo svp cfo treasur ir boston
may corp ndr svp financ ir san francisco
page
feb interactivecorp angi homeservic angi group meet ceo cfo ir new york
may north america investor day sponsor strh boston new
march properti tour inc washington new
march cigna corpor ci hq visit presid ceo execut vice presid cfo execut vice
presid strategi suppli chain specialti presid strategi presid express script ci servic
presid us govern busi connecticut
feb tobey sommer business/govern servic detroit chicago
feb stephani benjamin automot services/truck logist midatlant canada
page
march jennif demba michael young bank texa
march ki bin michael lewi reit canada
march jennif demba michael young bank mid atlant
march ki bin michael lewi reit boston midatlant new
march jennif demba michael young bank new york
april ki bin michael lewi reit mid-west new
april ki bin michael lewi reit tx southeast new
page
issu research report suntrust robinson humphrey inc analyst name report herebi certifi
recommend opinion express accur reflect research analyst person view
subject secur compani discuss herein part research analyst compens directli
indirectli relat specif recommend view express report
